Update from NIH: Perspectives on Extramural Scientists and Science
Michael Lauer, M.D., is the Deputy Director for Extramural Research at the National Institutes of Health (NIH), where he serves as the principal scientific leader and advisor to the Director of the NIH on all matters relating to the substance, quality, and effectiveness of the NIH extramural research program and administration. Dr. Lauer will review recent extramural research developments and priorities, including the resilience of the biomedical research workforce and the performance of the biomedical research enterprise.
Dr. Lauer received education and training at Rensselaer Polytechnic Institute, Albany Medical College, Harvard Medical School, Harvard School of Public Health, and the NHLBI’s Framingham Heart Study. He spent 14 years at Cleveland Clinic as Professor of Medicine, Epidemiology, and Biostatistics. During his tenure at the Clinic, he led a federally funded internationally renowned clinical epidemiology program that applied big data from large-scale electronic health platforms to questions regarding the diagnosis and management of cardiovascular disease. From 2007 to 2015 he served as a Division Director at the National Heart, Lung, and Blood Institute (NHLBI), where promoted efforts to leverage big data infrastructure to enable high-efficiency population and clinical research and efforts to adopt a research funding culture that reflected data-driven policy. He has received numerous awards including the NIH Equal Employment Opportunity Award of the Year and the Arthur S. Flemming Award for Exceptional Federal Service in recognition of his efforts to grow a culture of learning and accountability.
Dr. Michael Lauer will be the late morning plenary speaker for the 10th Annual NORDP Research Development Conference on May 9. We hope to see you at the Conference, which will be held May 7-9, 2018 at the Hyatt Regency Crystal City in Arlington, VA. Follow @NORDP_official on Twitter for all the latest #NORDP2018 updates.
2 thoughts on “NORDP 2018 Plenary: Update from NIH with Dr. Michael Lauer”